Alison Holmes
Alison Helen Holmes is a British infectious diseases specialist, who is a professor at Imperial College London and the University of Liverpool.[1] Holmes serves as Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance and Consultant at Hammersmith Hospital. Holmes is on the Executive Committee of the International Society of Infectious Diseases, and she serves on a variety of World Health Organization (WHO) expert groups related to antimicrobial use, Antimicrobial Resistance (AMR), infection prevention and sepsis. Her research considers how to mitigate antimicrobial resistance.[2] Early life and educationHolmes went to school in Dar es Salaam, Tanzania. Her father was a doctor in Nigeria.[3] Holmes completed her Bachelor of Medicine, Bachelor of Surgery degree in medicine at the University of Cambridge and St George’s Hospital Medical School. She specialised in Infectious Diseases and General (Internal) Medicine. Research and careerAntimicrobial resistance (AMR) represents a major threat to healthcare. There are increasing numbers of bacteria that can no longer be treated with antibiotics.[4] At Imperial College London Holmes leads Centre for Antimicrobial Optimisation, a research centre that looks to tackle drug-resistant infection.[5] She is Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and AMR.[6] In 2023, Holmes launched the Centres for Antimicrobial Optimisation Network (CAMO-Net),[7] a Wellcome Trust funded research collaboration of universities based in 11 different countries, designed to address antimicrobial resistance and support antimicrobial optimisation for use in humans.[8] Selected publications
Honours and awardsHolmes was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2017.[9] She was appointed Officer of the Order of the British Empire (OBE) in the 2021 Birthday Honours for services to medicine and infectious diseases, particularly during Covid-19.[10] References
|